Eliem Therapeutics (NASDAQ:ELYM) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of $(0.38) by 23.68 percent. This is a 27.5 percent increase over losses of $(0.40) per share from the same period last year.
LendingClub Q3 EPS $0.26 May Not Compare To $0.03 Estimate, Sales $246.20M Beat $221.19M Estimate
LendingClub (NYSE:LC) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.03 by 766.67 percent. This is a 204 percent increase over losses of $(0.25) per share from the same
